Table 1 Participant characteristics of a randomized controlled trial evaluating a web-based intervention for improving self-reported cognitive functioning in adult cancer survivors
Intervention N = 121 | Control N = 121 | Combined N = 242 | |
|---|---|---|---|
Female | 116 (96%) | 114 (94%) | 230 (95%) |
Age (range); years | 52 (23–74) | 54 (31–74) | 53 (23–74) |
Median education (range); years | 14 (8–19) | 12 (3–19) | 13 (8–19) |
English as first language | 117 (97%) | 117 (97%) | 234 (97%) |
Primary tumor type | |||
Breast | 108 (89%) | 108 (89%) | 216 (89%) |
Colorectal | 6 (5%) | 7 (6%) | 13 (5%) |
Other | 7 (6%) | 6 (5%) | 13 (5%) |
Time since completion of chemotherapy, months, mean (range) | 27 (6–57) | 27 (6–60) | 27 (6–60) |
Radiotherapy | 86 (71%) | 78 (64%) | 164 (68%) |
Immune therapy | 30 (25%) | 24 (20%) | 54 (22%) |
Hormone therapy | 84 (69%) | 85 (70%) | 171 (71%) |
Previous neurological historya | 20 (17%) | 30 (25%) | 50 (21%) |